ObjectiveTo evaluate the associated factors for predicting anatomical outcomes of idiopathic macular hole (IMH) after vitrectomy. MethodsThis is a retrospective study. A total of 165 eyes in 164 IMH patients underwent a successful vitrectomy and ILM peeling surgery were included in this study.The patients included 43 males and 121 females, with the mean age of (64.0±6.7) years. The corrected vision acuity of logarithm of the minimum angle of resolution (logMAR), indirect ophthalmoscope and spectral domain optical coherence tomography (SD-OCT) were measured for all patients. The mean logMAR corrected vision acuity was 1.0. The duration of disease was (8.7±14.9) months. The minimum diameter (MIN), base diameter (BASE) and height (H) were 521, 1010, 406 μm respectively. The macular hole index (MHI), tractional hole index (THI), diameter hole index (DHI) and macular hole closure index (MHCI) were 0.43, 0.82, 0.57, 0.92 respectively. Anatomical outcomes were divided into 3 levels. A: bridge-shaped healing; B: good healing; C: poor healing. The mean follow-up was (3.6±3.2) months. The multiple factors related with prognosis including age, sex, duration of disease, preoperative logMAR corrected vision acuity, MIN, BASE and H, MHI, THI, DHI, MHCI were analyzed. ResultsDuration of disease (r=0.141), preoperative logMAR corrected vision acuity (r=0.082), age (r=0.044), sex (r=0.109) was independent of anatomical prognosis (P > 0.05). MIN (r=0.397), BASE (r=0.276), H (r=-0.240), MHI (r=-0.363), THI (r=-0.432), DHI (r=0.272) was weak correlation to anatomical prognosis (P < 0.05). MHCI correlated significantly with anatomical outcomes (r=-0.543, P=0.000). The median MHCI of A, B and C were 1.07, 0.91, 0.56 respectively. There were significant difference of MHCI among the three levels (H=52.857, P < 0.05). ConclusionsMHCI has the best correlation with anatomical outcomes. It can be considered a key factor for predicting anatomical outcomes of IMH after vitrectomy.
ObjectiveTo evaluate the efficacy of 30% and 50% dose photodynamic therapy (PDT) for acute central serous chorioretinopathy (CSC). MethodsA retrospective cohort study. Ninety-two eyes of 88 patients with CSC, diagnosed by best corrected visual acuity (BCVA) of logarithm of the minimum angle of resolution (logMAR), indirect ophthalmoscope, fundus colorized photography, fundus fluorescein angiography (FFA), indocyanine green angiography (ICGA)and optical coherence tomography (SD-OCT) treated with 30% and 50% doses of verteporfin respectively between March 2007 and August 2013, were enrolled. The eyes were divided into 50% dose group (49 eyes) and 30% dose group (43 eyes). The differences of age (t=-1.45), gender (χ2=0.011), eyes (χ2=2.140), mean logMAR BCVA (t=-0.40), mean central retinal thickness (CRT) and the maximum thickness of serous retinal detachment (SRD) between two groups were not significant (P > 0.05). The difference of spot size between two groups was significant (t=-2.84, P < 0.05). The follow-up time was ranged from 6 to 68 months, with a mean of (17.16 ±11.30) months. The difference of follow-up between two groups was significant (P > 0.05). The BCVA, cure rate, recurrence rate and the changes of CRT and maximum SRT were observed by SD-OCT. ResultsThe subretinal fluid (SRF) of 31 eyes (72.09%) in the 30% dose group and that of 47 eyes (95.92%) in the 50% dose PDT group was absorbed completely respectively. The cure rates in the 30% dose PDT group was significantly less than that in the 50% dose group (χ2=10.077, P=0.020). There was a significant negative association between the cure rate and spot size by Logistic regression (odds ratio > 1, P=0.040). The difference of changes in the BCVA of logMAR in 50% dose group was better than that in 30% dose group after more than 12 months after PDT (P=0.036). On 3, 6, 12 and more than 12 months after PDT, the difference in CRT in 50% dose group and 30% dose group were not statistically significant (P=0.068, 0.060, 0.082, 0.067). The difference in maximum thickness of SRD was not statically significant (P > 0.05). SRF was appeared in 8 eyes (25.81%) of 31 eyes in the 30% dose group, while SRF was appeared in 1 eye (2.13%) of 47 eyes in the 50% dose group. The recurrence rate of 30% dose group was much higher than that of 50% dose group (P < 0.05). ConclusionsFor acute CSC treated by PDT, the curative effect of 50% dose group is better than the 30% dose group.